LGMD 2L (LGMD R12) is associated with mutations in the ANO5 gene, which encodes for the Anoctamin 5 protein necessary for achieving functional calcium-activated chloride channels in the muscles [53]. The gene discussed is ANO5; the disease is limb-girdle muscular dystrophy.